Individual patient risk assessment and cost-benefit analysis of patiromer in AMBER. O'Sullivan ED, MacIntyre IM. Lancet 2020;396:311.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

O'Sullivan ED, MacIntyre IM. Individual patient risk assessment and cost-benefit analysis of patiromer in AMBER. Lancet 2020;396:311.
PMID: 32738951